Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage.

Takashima S, Martin ML, Jansen SA, Fu Y, Bos J, Chandra D, O'Connor MH, Mertelsmann AM, Vinci P, Kuttiyara J, Devlin SM, Middendorp S, Calafiore M, Egorova A, Kleppe M, Lo Y, Shroyer NF, Cheng EH, Levine RL, Liu C, Kolesnick R, Lindemans CA, Hanash AM.

Sci Immunol. 2019 Dec 6;4(42). pii: eaay8556. doi: 10.1126/sciimmunol.aay8556.

PMID:
31811055
2.

Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis.

Shimauchi A, Abe H, Schacht DV, Yulei J, Pineda FD, Jansen SA, Ganesh R, Newstead GM.

Eur Radiol. 2015 Aug;25(8):2470-8. doi: 10.1007/s00330-015-3635-1. Epub 2015 Feb 20.

PMID:
25698353
3.

High resolution 3D MRI of mouse mammary glands with intra-ductal injection of contrast media.

Markiewicz E, Fan X, Mustafi D, Zamora M, Roman BB, Jansen SA, Macleod K, Conzen SD, Karczmar GS.

Magn Reson Imaging. 2015 Jan;33(1):161-5. doi: 10.1016/j.mri.2014.08.035. Epub 2014 Aug 29.

4.

A review of analytical methods for eicosanoids in brain tissue.

Puppolo M, Varma D, Jansen SA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 1;964:50-64. doi: 10.1016/j.jchromb.2014.03.007. Epub 2014 Mar 14. Review.

5.

Lipid composition of thermophilic Geobacillus sp. strain GWE1, isolated from sterilization oven.

Shah SP, Jansen SA, Taylor LJ, Chong PL, Correa-Llantén DN, Blamey JM.

Chem Phys Lipids. 2014 May;180:61-71. doi: 10.1016/j.chemphyslip.2014.02.005. Epub 2014 Mar 5.

PMID:
24613478
6.

Grayanotoxin poisoning: 'mad honey disease' and beyond.

Jansen SA, Kleerekooper I, Hofman ZL, Kappen IF, Stary-Weinzinger A, van der Heyden MA.

Cardiovasc Toxicol. 2012 Sep;12(3):208-15. doi: 10.1007/s12012-012-9162-2. Review.

7.

T(2)∗ relaxation times of intraductal murine mammary cancer, invasive mammary cancer, and normal mammary gland.

Hipp E, Fan X, Jansen SA, Markiewicz EJ, Vosicky J, Newstead GM, Conzen SD, Krausz T, Karczmar GS.

Med Phys. 2012 Mar;39(3):1309-13. doi: 10.1118/1.3684950.

8.

Ductal carcinoma in situ: detection, diagnosis, and characterization with magnetic resonance imaging.

Jansen SA.

Semin Ultrasound CT MR. 2011 Aug;32(4):306-18. doi: 10.1053/j.sult.2011.02.007. Review.

PMID:
21782121
9.

The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast.

Jansen SA, Shimauchi A, Zak L, Fan X, Karczmar GS, Newstead GM.

J Magn Reson Imaging. 2011 Jun;33(6):1382-9. doi: 10.1002/jmri.22567.

10.

Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?".

Varma D, Ganti S, Gilles T, Diaz M, Thompson T, Stull J, Jansen SA.

Bioanalysis. 2011 Apr;3(8):853-62. doi: 10.4155/bio.11.58.

PMID:
21510759
12.

Normal parenchymal enhancement patterns in women undergoing MR screening of the breast.

Jansen SA, Lin VC, Giger ML, Li H, Karczmar GS, Newstead GM.

Eur Radiol. 2011 Jul;21(7):1374-82. doi: 10.1007/s00330-011-2080-z. Epub 2011 Feb 17.

PMID:
21327872
13.

In vivo MRI of early stage mammary cancers and the normal mouse mammary gland.

Jansen SA, Conzen SD, Fan X, Markiewicz E, Krausz T, Newstead GM, Karczmar GS.

NMR Biomed. 2011 Aug;24(7):880-7. doi: 10.1002/nbm.1643. Epub 2011 Jan 25.

14.

Chromatography with higher pressure, smaller particles and higher temperature: a bioanalytical perspective.

Varma D, Jansen SA, Ganti S.

Bioanalysis. 2010 Dec;2(12):2019-34. doi: 10.4155/bio.10.148. Review.

PMID:
21110745
15.

Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study.

Jansen SA, Fan X, Medved M, Abe H, Shimauchi A, Yang C, Zamora M, Foxley S, Olopade OI, Karczmar GS, Newstead GM.

Phys Med Biol. 2010 Oct 7;55(19):N473-85. doi: 10.1088/0031-9155/55/19/N02. Epub 2010 Sep 21.

PMID:
20858914
16.

Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers.

Chen W, Giger ML, Newstead GM, Bick U, Jansen SA, Li H, Lan L.

Acad Radiol. 2010 Jul;17(7):822-9. doi: 10.1016/j.acra.2010.03.007.

17.

Breast cancers not detected at MRI: review of false-negative lesions.

Shimauchi A, Jansen SA, Abe H, Jaskowiak N, Schmidt RA, Newstead GM.

AJR Am J Roentgenol. 2010 Jun;194(6):1674-9. doi: 10.2214/AJR.09.3568.

PMID:
20489112
18.

Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.

Bhooshan N, Giger ML, Jansen SA, Li H, Lan L, Newstead GM.

Radiology. 2010 Mar;254(3):680-90. doi: 10.1148/radiol.09090838. Epub 2010 Feb 1.

19.

Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model.

Jansen SA, Paunesku T, Fan X, Woloschak GE, Vogt S, Conzen SD, Krausz T, Newstead GM, Karczmar GS.

Radiology. 2009 Nov;253(2):399-406. doi: 10.1148/radiol.2533082026.

20.

Relating dose of contrast media administered to uptake and washout of malignant lesions on DCEMRI of the breast.

Jansen SA, Fan X, Yang C, Shimauchi A, Karczmar G, Newstead GM.

Acad Radiol. 2010 Jan;17(1):24-30. doi: 10.1016/j.acra.2009.06.015.

PMID:
19836270

Supplemental Content

Loading ...
Support Center